Last Updated: June 22, 2026

LEVOCETIRIZINE Drug Patent Profile

Name: LEVOCETIRIZINE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Levocetirizine patents expire, and what generic alternatives are available?

Levocetirizine is a drug marketed by Apotex, Chartwell Molecular, Padagis Us, Taro, Dr Reddys, Dr Reddys Labs Ltd, Glenmark Pharms Ltd, Granules, Hetero Labs Ltd Iii, Ipca Labs Ltd, Macleods Pharms Ltd, Micro Labs Ltd India, Perrigo R And D, Sankalp Lifecare, Sciegen Pharms, Sun Pharm, Sun Pharm Inds Ltd, Synthon Bv, Teva Pharms, and Us Antibiotics. and is included in twenty-four NDAs.

The generic ingredient in LEVOCETIRIZINE is levocetirizine dihydrochloride. There are thirteen drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the levocetirizine dihydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Levocetirizine

A generic version of LEVOCETIRIZINE was approved as levocetirizine dihydrochloride by SYNTHON BV on November 26^th, 2010.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for LEVOCETIRIZINE?
What are the global sales for LEVOCETIRIZINE?
What is Average Wholesale Price for LEVOCETIRIZINE?

Summary for LEVOCETIRIZINE

US Patents:	0
Applicants:	20
NDAs:	24
Drug Prices:	Drug price information for LEVOCETIRIZINE
Drug Sales Revenues:	Drug sales revenues for LEVOCETIRIZINE
DailyMed Link:	LEVOCETIRIZINE at DailyMed

Drug patent expirations by year for LEVOCETIRIZINE

US Patents and Regulatory Information for LEVOCETIRIZINE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Apotex	LEVOCETIRIZINE DIHYDROCHLORIDE	levocetirizine dihydrochloride	SOLUTION;ORAL	202915-001	Aug 21, 2014		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sciegen Pharms	LEVOCETIRIZINE DIHYDROCHLORIDE	levocetirizine dihydrochloride	TABLET;ORAL	203646-001	Sep 9, 2014	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Hetero Labs Ltd Iii	LEVOCETIRIZINE HYDROCHLORIDE	levocetirizine dihydrochloride	SOLUTION;ORAL	210914-001	Apr 1, 2019	AA	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Dr Reddys	LEVOCETIRIZINE DIHYDROCHLORIDE	levocetirizine dihydrochloride	TABLET;ORAL	210375-001	Jan 19, 2018		OTC	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Taro	LEVOCETIRIZINE DIHYDROCHLORIDE	levocetirizine dihydrochloride	SOLUTION;ORAL	202673-001	Jul 26, 2013		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for LEVOCETIRIZINE

Levocetirizine dihydrochloride paten?
Generic for levocetirizine?
Levocetirizine dihydrochloride vs levocetirizine hydrochloride?
Levocetirizine dihydrochloride vs hydrochloride?
Levocetirizine dihydrochloride market?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.